SYSergio Seiji Yamada

Sergio Seiji Yamada

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sergio Seiji Yamada has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Análise dos parâmetros de sarcopenia e quedas em pacientes em hemodiálise: nenhuma associação encontrada em um estudo transversal

    by João Vitor Oblanca, Thaís Larissa Reichert, César Faúndez-Casanova, Kauana Borges Marchini, Fábio Torres, Mariana Ardengue, Sergio Seiji Yamada, Ademar Avelar

    RESUMO Introdução: A sarcopenia está associada a um risco aumentado de quedas em diversas populações. Pacientes com doença renal crônica (DRC) em hemodiálise (HD) apresentam maior prevalência de fraqueza e atrofia muscular. O objetivo deste estudo foi investigar a associação entre parâmetros de sarcopenia e histórico de quedas nessa população. Métodos: Um estudo transversal foi realizado para avaliar 111 participantes com DRC em HD (54 ± 15,6 anos; 59,5% homens). A sarcopenia foi definida por baixa força muscular (dinamometria manual) e baixa massa muscular (impedância bioelétrica). O histórico de quedas foi autorreferido. Análises bivariadas foram realizadas, e um modelo de regressão logística multivariada foi utilizado para avaliar a associação entre sarcopenia e quedas, ajustado por fatores de confusão. Resultados: Na análise multivariada, a sarcopenia não foi independentemente associada ao histórico de quedas (OR = 1,73; p = 0,40). No entanto, a idade avançada (OR = 1,04 por ano; p = 0,03) e o histórico de AVC (OR = 6,07; p = 0,05) foram identificados como preditores independentes e significativos de quedas. Conclusão: O histórico de quedas não esteve independentemente associado à força ou à massa muscular em pacientes com DRC em HD. Estudos longitudinais futuros são necessários para investigar outros fatores associados a esse desfecho.

  • Open Access

    Analysis of sarcopenia parameters and falls in hemodialysis patients: no association found in a cross-sectional study

    by João Vitor Oblanca, Thaís Larissa Reichert, César Faúndez-Casanova, Kauana Borges Marchini, Fábio Torres, Mariana Ardengue, Sergio Seiji Yamada, Ademar Avelar

    Introduction: Sarcopenia has been associated with an increased risk of falls in diverse populations. Patients with end-stage renal disease (ESRD) undergoing hemodialysis (HD) have an increased prevalence of muscle weakness and wasting. The aim of this study was to investigate the association between parameters of sarcopenia and a history of falls in ESRD patients on HD. Methods: A cross-sectional study was utilized to assess 111 participants with ESRD on HD (54 ± 15.6 years; 59.5% men). Sarcopenia was defined by low muscle strength (handgrip dynamometry) and low muscle mass (bioelectrical impedance). History of falls was self-reported. Bivariate analyses were performed, and a multivariate logistic regression model was used to assess the association between sarcopenia and falls while adjusting for confounders. Results: In the multivariate analysis, sarcopenia was not independently associated with a history of falls (OR = 1.73; p = 0.40). However, advanced age (OR = 1.04 per year; p = 0.03) and a history of stroke (OR = 6.07; p = 0.05) were identified as significant independent predictors of falls. Conclusion: History of falls was not independently associated with muscle strength or mass in ESRD patients on HD. Future longitudinal studies are needed to investigate other factors associated with this outcome.

  • Open Access

    Analysis of the Association between Sarcopenia Parameters and Falls in Patients with Chronic Kidney Disease undergoing Hemodialysis: A Cross-Sectional Study

    by João Vitor Oblanca, Thaís Larissa Reichert, César Faúndez-Casanova, Kauana Borges Marchini, Fábio Torres, Mariana Ardengue, Sergio Seiji Yamada, Ademar Avelar

    Introduction: Sarcopenia has been associated with an increased risk of falls in diverse populations. Patients with end-stage kidney disease (ESRD) undergoing hemodialysis (HD) have an increased prevalence of muscle weakness and wasting. The aim of this study was to investigate the association between parameters of sarcopenia and a history of falls in ESRD patients in HD. Methods: A cross-sectional study design was utilized to assess 111 participants with ESRD in HD (54 ± 15.6 years; 59.5% men) in a tertiary hospital in Maringa-PR. Sarcopenia status was determined through the measure of muscle strength and mass. Muscle strength was assessed through hand grip strength utilizing a handheld dynamometer. Muscle mass was estimated through bioelectrical impedance. Falls’ history was assessed with the fifth question of the SARC-F questionnaire. Data normality was assessed with the Shapiro-Wilk test. The association of the sarcopenia parameters with a falls history was analyzed with the chi-square test and Cramér’s V to measure effect size. Results: No association was found among the parameters of sarcopenia or its diagnosis and a history of falls in this population ( p > 0.05). Participants who reported falling in the previous year were older (60 ± 16.7 vs. 51 ± 14.7 years, p = 0.01) and had a history of cerebrovascular disease (14.3% vs. 2.4%, p = 0.02). Conclusion: Falls history was not associated with muscle strength or mass in ESRD patients in HD. Future longitudinal studies are needed to investigate other factors associated with this outcome.

  • Open Access

    Efetividade da proteína / creatinina na amostra isolada de urina na avaliação da nefrite lupica

    by Sergio Seiji Yamada, Paulo Roberto Donadio, Sueny de Paula Munarin Sanches, Fernanda Borghi, Juliana Yuri Sekiyama

    O Lúpus Eritematoso Sistêmico (LES) é uma doença inflamatória crônica autoimune, cuja etiopatogenia envolve múltiplos genes, fatores hormonais e ambientais. Uma das mais sérias complicações do LES é a nefrite lúpica (NL), sendo definidora de mal prognóstico. Este estudo analítico observacional tem como objetivo avaliar a possibilidade de utilização da relação proteína/ creatinina em amostra isolada urinária para acompanhamento dos pacientes com nefrite lúpica, através da comparação com a proteinúria de 24 horas (P24h). Foram analisados e correlacionados os resultados de P24h e relação P/C urinária de 77 pacientes com LES acompanhados em um ambulatório especializado de um hospital universitário, sendo 34 deles com nefrite estabelecida e 43 sem evidências de nefrite. Foi realizada a análise de correlação e concordância, para tanto, sendo utilizados o coeficiente de correlação de Pearson, método de Bland-Altman plot, e coeficiente de concordância de Lin. Das amostras pareadas de 89 pacientes, 12 (13,5%) foram excluídas, 10 delas devido coleta inadequada e 2 por resultados de proteinúria em níveis nefróticos e destoantes com os demais. É importante considerar que a proteinúria de 24 horas permanece como o padrão ouro para o diagnóstico de doenças proteinúricas e é o parâmetro mais utilizado em doenças glomerulares. No entanto, a coleta de urina amostra isolada para determinar a relação P / C tem algumas vantagens em relação à facilidade de coleta, confiabilidade quanto ao seguimento das instruções, precisão e rápido diagnóstico.

  • Open Access

    Amoxicillin dosing and pharmacokinetics in obesity for the treatment of bacterial respiratory infection secondary to COVID-19: a systematic review

    by Gisela Myrian de Lima Leite Dalla Rosa, Sandra Regina Bin Silva, Sérgio Seiji Yamada, Paulo Jorge Pereira Alves Paixão, Maiara Camotti Montanha, Elza Kimura

    Objective: To conduct a systematic review of Amoxicillin (AMX) dosing and pharmacokinetics (PK) in obese subjects for the treatment of the outpatient respiratory tract infection which may be a secondary co-infection with COVID-19. Methodology: A systematic review was performed up to January 2022 on MEDLINE, EMBASE, and Web of Science. Full-text manuscripts describing AMX dosing for respiratory infection or PK in obese children, adults, and RYGB bariatric patients treated with AMX were included. Results: A total of 179 records were screened, of which 8 met the inclusion criteria. Four studies described AMX dosing in obese children and adults, while 4 described PK in obese adults and RYGB bariatric subjects. Overall, in the dosing studies, 54% of children >20 kg and 10% <40 kg with respiratory infection were considered underdosed, according to guidelines or recommendations. Underdosing of 10% occurred in both overweight and non-obese children’s groups. For morbidly obese adults, 70% were considered underdosed. In the PK studies, obese and bariatric adult subjects showed reduced exposure compared to normal weight patients for all AMX formulations. Conclusion: More PK studies are needed to confirm the optimal dose of AMX for obese patients, particularly in children. However, considering that all obese and bariatric adults had reduced exposure compared to subjects of normal weight, 1 g 8/8h should be recommended and liquid formulations are preferable for bariatric patients. To minimize the risks of therapeutic failure and avoid toxicity, a higher threshold of doses should be prescribed for obese children.

  • Open Access

    PREDICTION OF ALL-CAUSE MORTALITY AND CARDIOVASCULAR EVENTS IN END STAGE RENAL DISEASE WITH CENTRAL HAEMODYNAMICS: A SYSTEMATIC REVIEW PROTOCOL

    by Bárbara Letícia da Silva Guedes de Moura, Felipe Steinmacher Batista, Guilherme Luiz Rodrigues Ramajo, Gustavo Bueno Valente, João Vitor Scalon Estércio Rizzo, Tarik Radi Campos Maftoum, Izabel Galhardo Demarchi, Sérgio Seiji Yamada, Rogério Toshiro Passos Okawa, Jorge Juarez Vieira Teixeira

    Background Given the high rates of adverse events in End-stage renal disease (ESRD) patients and as the applications of central haemodynamics (central blood pressure, augmentation index, pulse wave velocity) in dialysis patients have not been fully clarified, we, therefore, will perform a systematic review of central haemodynamics as a predictor of total and cardiovascular mortality and morbidity in the ESRD population. Methods This protocol is reported according to the PRISMA-P guideline. The databases PubMed, EMBASE, LILACS, Web of Science, and Google Scholar system will be searched and double screening for prospective studies that assessed the prospective association of central haemodynamics parameters with at least one of the pre-specified outcomes in ESRD patients. Discrepancies will be resolved through consensus. A modified version of the Newcastle-Ottawa Quality Assessment Scale of cohort studies will be used. We intend to use the random-effects model, considering at least moderate heterogeneity between studies. If data allow, we will perform a sensitivity analysis to explore potential sources of between-study heterogeneity. Discussion This systematic review will summarize current evidence about central haemodynamics measures in the ESRD patients and clarify the incremental prognostic value of this diagnostic tool in these patients. Therefore, this systematic review will also be displayed important knowledge gaps in the current literature regarding the possible utility of central haemodynamics indices in ESRD patients. Systematic review registration This systematic review protocol was submitted to the PROSPERO international registry of systematic reviews (Registration number: CRD42022260824). Strengths and limitations of this study → The PROSPERO registry helps to promote and maintain transparency in the process and to assist in minimizing the risk of bias. Four databases and one additional grey literature source helps ensure more complete coverage of the topic. All the review phases will be peer-reviewed and will be validated by methodological and clinical experts. → Central (aortic, carotid) pressures are pathophysiologically more relevant than peripheral pressures for the pathogenesis of cardiovascular (CV) disease. There is a cumulative increase in CVD during the transition from CKD to ESRD: as patients initiate dialysis, there are significant changes in blood pressure, volume status, and circulating solutes, all of which may contribute to increased risk of CVD. Studies did not further analyze the ability of central pressures and indices to predict future events in separated stages of CKD, especially in End-stage renal disease patients (ESRD) patients. → This study has limitations. Because heterogeneity is quite common in these systematic reviews, there may be limited scope for meta-analysis. Possibly, the spectrum of patients in different research sites is the main factor, in most cases, but heterogeneity in associations between studies may be difficult to explain. → This systematic review will evaluate the evidence related to the Central Haemodynamics (central blood pressure, augmentation index, pulse wave velocity) incremental prognostic value in ESRD patients, which may lower morbidity and mortality and influence its use as a prognostic marker for ESRD patients.